Vania Tietsche de Moraes Hungria

26PUBLICATIONS
120CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Nuclear physicsNanomedicineHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 27, 2026
Real-world outcomes of daratumumab, bortezomib, thalidomide and dexamethasone (Dara-VTd) induction and lenalidomide maintenance in transplant-eligible multiple myeloma.

|Aug 19, 2026
Daratumumab plus bortezomib, lenalidomide, and dexamethasone in transplant-deferred newly diagnosed multiple myeloma: Frailty subgroup analysis of CEPHEUS.

|Jul 22, 2026
International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas.

|Jun 03, 2026
Daratumumab in transplant-ineligible or -deferred newly diagnosed multiple myeloma: minimal residual disease in CEPHEUS.

|May 12, 2026
Daratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis.

|Jan 27, 2026
Emerging Real-World Treatment Patterns and Clinical Outcomes of Multiple Myeloma in Argentina and Brazil: Insights from the TOTEMM Study in the Private Healthcare Sector.

Vania Hungria, Angelo Maiolino, Roberto Jose Pessoa de Magalhães

Pageof 5

Frequent Collaborators

7 joint publications

María-Victoria Mateos

6 joint publications

Angelo Maiolino

5 joint publications

Edvan Q Crusoé

4 joint publications

Meletios-Athanasios Dimopoulos